| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,979 |
14,904 |
$1.68M |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,052 |
3,001 |
$371K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,992 |
5,478 |
$353K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,798 |
2,748 |
$310K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,798 |
1,746 |
$197K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,471 |
3,138 |
$140K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,223 |
1,130 |
$126K |
| 92551 |
|
6,834 |
6,658 |
$65K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,611 |
2,368 |
$59K |
| 90686 |
|
1,612 |
1,589 |
$37K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
288 |
275 |
$34K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,316 |
3,225 |
$29K |
| 36415 |
Collection of venous blood by venipuncture |
9,482 |
9,165 |
$25K |
| 90619 |
|
606 |
589 |
$24K |
| 99177 |
|
6,248 |
6,113 |
$24K |
| 90620 |
|
982 |
972 |
$23K |
| 90651 |
|
972 |
941 |
$22K |
| 96127 |
|
4,526 |
4,394 |
$21K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,699 |
1,544 |
$17K |
| 90670 |
|
573 |
559 |
$13K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
71 |
64 |
$9K |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
1,682 |
1,652 |
$8K |
| 92587 |
|
480 |
465 |
$7K |
| 90734 |
|
288 |
287 |
$7K |
| 90671 |
|
258 |
245 |
$6K |
| 90633 |
|
269 |
257 |
$6K |
| 90698 |
|
257 |
249 |
$6K |
| 87807 |
|
527 |
456 |
$6K |
| 90697 |
|
104 |
104 |
$5K |
| 90715 |
|
186 |
179 |
$4K |
| 90680 |
|
152 |
150 |
$3K |
| 99173 |
|
1,403 |
1,354 |
$3K |
| 90688 |
|
134 |
134 |
$3K |
| 90710 |
|
91 |
91 |
$2K |
| 90744 |
|
69 |
65 |
$2K |
| 90672 |
|
50 |
50 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
90 |
82 |
$1K |
| 90677 |
|
13 |
13 |
$936.00 |
| 90681 |
|
25 |
25 |
$582.00 |
| 81003 |
|
340 |
321 |
$511.60 |
| 90661 |
|
15 |
14 |
$479.05 |
| 90700 |
|
13 |
13 |
$279.36 |
| 96160 |
|
580 |
566 |
$208.64 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
100 |
93 |
$77.35 |
| A7015 |
Aerosol mask, used with dme nebulizer |
100 |
93 |
$60.85 |
| 94760 |
|
61 |
57 |
$49.40 |
| 36416 |
|
25 |
24 |
$6.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
90 |
82 |
$4.25 |
| 99000 |
|
12 |
12 |
$0.00 |
| S3620 |
Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) |
12 |
12 |
$0.00 |